Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00074646
Status:
COMPLETED
Last Update Posted:
2007-01-04
First Post:
2003-12-17
Brief Title:
Phase I Trial of CC-8490 for the Treatment of Subjects With RecurrentRefractory High-Grade Gliomas
Sponsor:
Celgene Corporation
Organization:
Celgene
Study Overview
Official Title:
Phase I Trial of CC-8490 for the Treatment of Subjects With RecurrentRefractory High-Grade Gliomas
Status:
COMPLETED
Status Verified Date:
2007-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Phase I trial of CC-8490 for the treatment of subjects with recurrentrefractory high-grade gliomas
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None